Factors Associated with the Complications of Hysteroscopic Myomectomy.

Rev Bras Ginecol Obstet

Department of Obstetrics and Gynecology, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil.

Published: August 2020


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective:  To evaluate the factors associated with complete myomectomy in a single surgical procedure and the aspects related to the early complications.

Methods:  A cross-sectional study with women with submucous myomas. The dependent variables were the complete myomectomy performed in a single hysteroscopic procedure, and the presence of early complications related to the procedure.

Results:  We identified 338 women who underwent hysteroscopic myomectomy. In 89.05% of the cases, there was a single fibroid to be treated. According to the classification of the International Federation of Gynecology and Obstetrics (Fédération Internationale de Gynécologie et d'Obstétrique, FIGO, in French), most fibroids were of grade 0 (66.96%), followed by grade 1 (20.54%), and grade 2 (12.50%). The myomectomies were complete in 63.31% of the cases, and the factors independently associated with complete myomectomy were the diameter of the largest fibroid (prevalence ratio [PR]: 0.97; 95% confidence interval [95%CI]: 0.96-0.98) and the classification 0 of the fibroid according to the FIGO (PR: 2.04; 95%CI: 1.18-3.52). We observed early complications in 13.01% of the hysteroscopic procedures (4.44% presented excessive bleeding during the procedure, 4.14%, uterine perforation, 2.66%, false route, 1.78%, fluid overload, 0.59%, exploratory laparotomy, and 0.3%, postoperative infection). The only independent factor associated with the occurrence of early complications was incomplete myomectomy (PR: 2.77; 95%CI: 1.43-5.38).

Conclusions:  Our results show that hysteroscopic myomectomy may result in up to 13% of complications, and the chance of complete resection is greater in small and completely intracavitary fibroids; women with larger fibroids and with a high degree of myometrial penetration have a greater chance of developing complications from hysteroscopic myomectomy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309217PMC
http://dx.doi.org/10.1055/s-0040-1713915DOI Listing

Publication Analysis

Top Keywords

hysteroscopic myomectomy
16
complete myomectomy
12
early complications
12
factors associated
8
complications hysteroscopic
8
myomectomy
8
associated complete
8
complications
6
hysteroscopic
6
complete
5

Similar Publications

Background: Reproductive-age women with intrauterine adhesions (IUAs) following uterine surgery may be asymptomatic or may experience light or absent menstruation, infertility, preterm delivery, and/or peripartum hemorrhage. Understanding procedure- and technique-specific risks and the available evidence on the impact of surgical adjuvants is essential to the design of future research.

Objective And Rationale: While many systematic reviews have been published, most deal with singular aspects of the problem.

View Article and Find Full Text PDF

Objective: To evaluate transvaginal radiofrequency ablation (TRFA) as a preoperative strategy to facilitate hysteroscopic resection in patients with complex submucosal fibroids desiring uterine preservation.

Design: Prospective case series.

Setting: Single tertiary hospital (Puerta de Hierro University Hospital, Madrid, Spain), January 2021-June 2023.

View Article and Find Full Text PDF

The management of symptomatic uterine fibroids depends on various factors, including patient preferences and individual considerations. The management options are multimodal, including medical and surgical therapies. In this report, we present the case of a 33-year-old female patient with submucosal uterine fibroids managed through laparoscopic myomectomy, chosen over hysteroscopic myomectomy based on the patient's specific preferences and clinical indications.

View Article and Find Full Text PDF

The advent of widespread genomic testing of uterine mesenchymal tumors has led to novel insights into the biology of these diverse tumors, and many genomically-defined entities have been described in recent years. During a larger study of endometrial stromal sarcomas and unclassified uterine sarcomas, we identified three tumors harboring KDM2B gene fusions. Patients were 32, 61, and 67 years old and all initially underwent incomplete sampling via laparoscopic myomectomy (n=1), laparoscopic biopsy (n=1), or hysteroscopic myomectomy (n=1).

View Article and Find Full Text PDF